These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 35791909)
1. Exploring mechanisms of Chaihu-Shugan-San against liver fibrosis by integrated multi-omics and network pharmacology approach. Xie Z; Xie Z; Trujillo NP; Yang T; Yang C Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35791909 [TBL] [Abstract][Full Text] [Related]
2. A Serum Pharmacochemistry and Network Pharmacology-based Approach to Study the Anti-depressant Effect of Chaihu-Shugan San. Deng MF; Yan YZ; Zhu SS; Zhou K; Tan SJ; Zeng P Comb Chem High Throughput Screen; 2024 Mar; ():. PubMed ID: 38551057 [TBL] [Abstract][Full Text] [Related]
3. Mechanism underlying effect of Chaihu Shugan San on major depressive disorder: a network pharmacology-based study. Mu J; Zhang S; Tang F; Liu S; Zhang Q; Du Q; Wang X; Wang Q; Cheng F J Tradit Chin Med; 2021 Apr; 41(2):338-348. PubMed ID: 33825416 [TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San. Zhang S; Lu Y; Chen W; Shi W; Zhao Q; Zhao J; Li L Drug Des Devel Ther; 2021; 15():3425-3441. PubMed ID: 34385814 [TBL] [Abstract][Full Text] [Related]
5. Effects and mechanisms of Xiaochaihu Tang against liver fibrosis: An integration of network pharmacology, molecular docking and experimental validation. Wang SJ; Ye W; Li WY; Tian W; Zhang M; Sun Y; Feng YD; Liu CX; Liu SY; Cao W; Meng JR; Li XQ J Ethnopharmacol; 2023 Mar; 303():116053. PubMed ID: 36529247 [TBL] [Abstract][Full Text] [Related]
6. An optimized herbal combination for the treatment of liver fibrosis: Hub genes, bioactive ingredients, and molecular mechanisms. Zhao Q; Bai J; Chen Y; Liu X; Zhao S; Ling G; Jia S; Zhai F; Xiang R J Ethnopharmacol; 2022 Oct; 297():115567. PubMed ID: 35870684 [TBL] [Abstract][Full Text] [Related]
7. Protective Effects of Chaihu Shugan San () on Nonalcoholic Fatty Liver Disease in Rats with Insulin Resistance. Jiang WN; Li D; Jiang T; Guo J; Chen YF; Wang J; Zhou Y; Yang CY; Tang CP Chin J Integr Med; 2018 Feb; 24(2):125-132. PubMed ID: 27164963 [TBL] [Abstract][Full Text] [Related]
8. Changes in regional cerebral blood flow with Chaihu-Shugan-San in the treatment of major depression. Qiu J; Hu SY; Shi GQ; Wang SE Pharmacogn Mag; 2014 Oct; 10(40):503-8. PubMed ID: 25422553 [TBL] [Abstract][Full Text] [Related]
9. A combined molecular biology and network pharmacology approach to investigate the multi-target mechanisms of Chaihu Shugan San on Alzheimer's disease. Zeng Q; Li L; Siu W; Jin Y; Cao M; Li W; Chen J; Cong W; Ma M; Chen K; Wu Z Biomed Pharmacother; 2019 Dec; 120():109370. PubMed ID: 31563815 [TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like activity of Chaihu-Shugan-San aqueous extract in rats and its possible mechanism. Wang S; Hu S; Zhang C; Qiu J; Li Y Pharmacogn Mag; 2014 Jan; 10(Suppl 1):S50-6. PubMed ID: 24914308 [TBL] [Abstract][Full Text] [Related]
11. Antidepressant-like effects of Chaihu-Shugan-San via SAPK/JNK signal transduction in rat models of depression. Li YH; Zhang CH; Qiu J; Wang SE; Hu SY; Huang X; Xie Y; Wang Y; Cheng TL Pharmacogn Mag; 2014 Jul; 10(39):271-7. PubMed ID: 25210314 [TBL] [Abstract][Full Text] [Related]
12. A network pharmacology-based approach to explore the effects of Chaihu Shugan powder on a non-alcoholic fatty liver rat model through nuclear receptors. Nie H; Deng Y; Zheng C; Pan M; Xie J; Zhang Y; Yang Q J Cell Mol Med; 2020 May; 24(9):5168-5184. PubMed ID: 32189432 [TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology Prediction and Molecular Docking-Based Strategy to Discover the Potential Pharmacological Mechanism of Huai Hua San Against Ulcerative Colitis. Liu J; Liu J; Tong X; Peng W; Wei S; Sun T; Wang Y; Zhang B; Li W Drug Des Devel Ther; 2021; 15():3255-3276. PubMed ID: 34349502 [TBL] [Abstract][Full Text] [Related]
14. [Therapeutic mechanism of the Mongolian medicine Zhang C; Yan Y; Gao X; Ma Y Nan Fang Yi Ke Da Xue Xue Bao; 2021 Aug; 41(8):1131-1141. PubMed ID: 34549702 [TBL] [Abstract][Full Text] [Related]
15. Chaihu-shugan san inhibits inflammatory response to improve insulin signaling in liver and prefrontal cortex of CUMS rats with glucose intolerance. Jia KK; Pan SM; Ding H; Liu JH; Zheng YJ; Wang SJ; Pan Y; Kong LD Biomed Pharmacother; 2018 Jul; 103():1415-1428. PubMed ID: 29864926 [TBL] [Abstract][Full Text] [Related]
16. Chaihu Shugan San promotes gastric motility in rats with functional dyspepsia by regulating Drp-1-mediated ICC mitophagy. Li L; Jia Q; Wang X; Wang Y; Wu C; Cong J; Ling J Pharm Biol; 2023 Dec; 61(1):249-258. PubMed ID: 36655341 [TBL] [Abstract][Full Text] [Related]
17. Potential Molecular Mechanisms of Chaihu-Shugan-San in Treatment of Breast Cancer Based on Network Pharmacology. Xiao K; Li K; Long S; Kong C; Zhu S Evid Based Complement Alternat Med; 2020; 2020():3670309. PubMed ID: 33062007 [TBL] [Abstract][Full Text] [Related]
18. A Comparison Study of Chaihu Shugan San and Fluoxetine on Antidepression and Regulating Blood Rheology Effects with Chronic Restrained Stress Rats. Qian M; Peng R; Yue C; Yang Z; Zhu H; Liu B; Xie M Evid Based Complement Alternat Med; 2020; 2020():6426383. PubMed ID: 39295891 [TBL] [Abstract][Full Text] [Related]
19. Systematic profiling of the effective ingredients and mechanism of Scabiosa comosa and S. tschilliensis against hepatic fibrosis combined with network pharmacology. Chen Q; Wang Y; Ma F; Han M; Wang Z; Xue P; Lu J Sci Rep; 2021 Jan; 11(1):2600. PubMed ID: 33510287 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic study of the prokinetic compounds meranzin hydrate and ferulic acid following oral administration of Chaihu-Shugan-San to patients with functional dyspepsia. Qiu XJ; Huang X; Chen ZQ; Ren P; Huang W; Qin F; Hu SH; Huang J; He J; Liu ZQ; Zhou HH J Ethnopharmacol; 2011 Sep; 137(1):205-13. PubMed ID: 21605652 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]